71,779 Shares in Acadia Healthcare Company, Inc. $ACHC Acquired by Invenomic Capital Management LP

Key Points

• Invenomic Capital Management LP purchased a new stake of approximately $2.18 million in Acadia Healthcare Company, acquiring 71,779 shares in the first quarter.
• Several institutional investors increased their positions in Acadia Healthcare, with GAMMA Investing LLC growing its holdings by 143.8%.
• Acadia Healthcare reported earnings of $0.83 per share, exceeding analysts’ expectations, with a revenue of $869.23 million for the quarter.

Invenomic Capital Management LP acquired a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 71,779 shares of the company's stock, valued at approximately $2,176,000. Invenomic Capital Management LP owned approximately 0.08% of Acadia Healthcare at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. GAMMA Investing LLC raised its holdings in shares of Acadia Healthcare by 143.8% in the first quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock valued at $176,000 after buying an additional 3,428 shares during the last quarter. Envestnet Portfolio Solutions Inc. purchased a new stake in shares of Acadia Healthcare in the first quarter valued at about $222,000. PNC Financial Services Group Inc. raised its holdings in shares of Acadia Healthcare by 10.3% in the first quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company's stock valued at $202,000 after buying an additional 622 shares during the last quarter. Raiffeisen Bank International AG raised its holdings in shares of Acadia Healthcare by 33.3% in the first quarter. Raiffeisen Bank International AG now owns 160,000 shares of the company's stock valued at $4,819,000 after buying an additional 40,000 shares during the last quarter. Finally, Teacher Retirement System of Texas purchased a new stake in shares of Acadia Healthcare in the first quarter valued at about $412,000.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on ACHC. Cowen reaffirmed a "buy" rating on shares of Acadia Healthcare in a report on Thursday, August 7th. UBS Group cut their price target on shares of Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating for the company in a report on Thursday, August 7th. Barclays cut their price target on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a report on Thursday, August 7th. Stephens raised shares of Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. Finally, Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Sunday, August 3rd. Eight equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $39.00.

Acadia Healthcare Price Performance

ACHC traded up $1.07 on Thursday, hitting $22.13. 753,398 shares of the company were exchanged, compared to its average volume of 2,224,624. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. The business's fifty day moving average is $22.16 and its 200 day moving average is $24.55. Acadia Healthcare Company, Inc. has a fifty-two week low of $17.13 and a fifty-two week high of $79.82. The firm has a market capitalization of $2.04 billion, a P/E ratio of 14.63, a price-to-earnings-growth ratio of 4.58 and a beta of 0.89.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The company had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. During the same period in the prior year, the business posted $0.91 earnings per share. The firm's revenue for the quarter was up 9.2% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.